StockDuty ← Dashboard Nov 10, 2026 07:27 AM ET
SignalEU/UK

Integra LifeSciences Holdings Corporation (IART) Presents at 2026 UBS Global Healthcare Conference Transcript

High-priority alert based on source significance and keyword relevance.

What happened: Integra LifeSciences CFO Lea Knight spoke at the 2026 UBS Global Healthcare Conference, saying procedure volumes in the company's neurosurgery and tissue reconstruction markets are largely stable. Key numbers: Conference dated November 9, 2026, 2:45 PM EST. Why it matters: Knight said customers care about clinical evidence, product differentiation, supplier reliability and ease of contracting, and noted the company created a Chief Commercial Officer role earlier this year to consolidate commercial and contracting activities.
Integra LifeSciences CFO Lea Knight spoke at the 2026 UBS Global Healthcare Conference, saying procedure volumes in the company's neurosurgery and tissue reconstruction markets are largely stable.
Knight said customers care about clinical evidence, product differentiation, supplier reliability and ease of contracting, and noted the company created a Chief Commercial Officer role earlier this year to consolidate commercial and contracting activities.
Sources